Seelos Therapeutics Management
Management criteria checks 3/4
Seelos Therapeutics' CEO is Raj Mehra, appointed in Jan 2019, has a tenure of 5.08 years. total yearly compensation is $1.73M, comprised of 34% salary and 66% bonuses, including company stock and options. directly owns 1.35% of the company’s shares, worth €141.66K. The average tenure of the management team and the board of directors is 3.6 years and 5.1 years respectively.
Key information
Raj Mehra
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 34.0% |
| CEO tenure | 5.1yrs |
| CEO ownership | 1.4% |
| Management average tenure | 3.6yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$51m |
| Jun 30 2023 | n/a | n/a | -US$81m |
| Mar 31 2023 | n/a | n/a | -US$73m |
| Dec 31 2022 | US$2m | US$562k | -US$74m |
| Sep 30 2022 | n/a | n/a | -US$82m |
| Jun 30 2022 | n/a | n/a | -US$73m |
| Mar 31 2022 | n/a | n/a | -US$61m |
| Dec 31 2021 | US$16m | US$523k | -US$66m |
| Sep 30 2021 | n/a | n/a | -US$45m |
| Jun 30 2021 | n/a | n/a | -US$39m |
| Mar 31 2021 | n/a | n/a | -US$33m |
| Dec 31 2020 | US$4m | US$475k | -US$19m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$22m |
| Mar 31 2020 | n/a | n/a | -US$21m |
| Dec 31 2019 | US$709k | US$438k | -US$51m |
Compensation vs Market: Raj's total compensation ($USD1.73M) is above average for companies of similar size in the German market ($USD411.05K).
Compensation vs Earnings: Raj's compensation has been consistent with company performance over the past year.
CEO
Raj Mehra (62 yo)
5.1yrs
Tenure
US$1,726,476
Compensation
Dr. Raj Mehra, Ph D., J.D., was an Independent Director at Larkspur Health Acquisition Corp. since July 2021 and serves as its Director. He is Chairman, Chief Executive Officer and President of Seelos Ther...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.1yrs | US$1.73m | 1.35% $ 141.7k | |
| Chief Financial Officer | 2.4yrs | US$846.67k | 0.63% $ 66.1k | |
| Senior Director of Clinical Development & Operations | 3.6yrs | no data | no data | |
| Chief Communications Officer | 5.1yrs | no data | no data | |
| Head of Manufacturing & Technical Operations | no data | no data | no data | |
| Chief Medical Officer | no data | no data | no data | |
| Senior VP & Head of Clinical Operations | 1.3yrs | no data | no data |
3.6yrs
Average Tenure
Experienced Management: NXE's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.1yrs | US$1.73m | 1.35% $ 141.7k | |
| Independent Director | 2.4yrs | US$89.72k | 0.0085% $ 892.9 | |
| Independent Director | 10.9yrs | US$87.72k | 0.0013% $ 131.9 | |
| Independent Director | 5.1yrs | US$74.22k | 0.0039% $ 408.2 | |
| Independent Director | 5.1yrs | US$105.22k | 0% $ 0 |
5.1yrs
Average Tenure
59yo
Average Age
Experienced Board: NXE's board of directors are considered experienced (5.1 years average tenure).